rs144347039

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_019892.6(INPP5E):​c.1159+30T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0209 in 1,609,640 control chromosomes in the GnomAD database, including 501 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 40 hom., cov: 34)
Exomes 𝑓: 0.021 ( 461 hom. )

Consequence

INPP5E
NM_019892.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.57

Publications

2 publications found
Variant links:
Genes affected
INPP5E (HGNC:21474): (inositol polyphosphate-5-phosphatase E) The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
INPP5E Gene-Disease associations (from GenCC):
  • Joubert syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • MORM syndrome
    Inheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, ClinGen, Orphanet
  • COACH syndrome 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with ocular defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 9-136433125-A-T is Benign according to our data. Variant chr9-136433125-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261189.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0556 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INPP5ENM_019892.6 linkc.1159+30T>A intron_variant Intron 4 of 9 ENST00000371712.4 NP_063945.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INPP5EENST00000371712.4 linkc.1159+30T>A intron_variant Intron 4 of 9 1 NM_019892.6 ENSP00000360777.3
INPP5EENST00000676019.1 linkc.1057+30T>A intron_variant Intron 4 of 9 ENSP00000501984.1

Frequencies

GnomAD3 genomes
AF:
0.0169
AC:
2569
AN:
151564
Hom.:
40
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00714
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.0245
Gnomad ASJ
AF:
0.0810
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00684
Gnomad FIN
AF:
0.00292
Gnomad MID
AF:
0.0478
Gnomad NFE
AF:
0.0215
Gnomad OTH
AF:
0.0279
GnomAD2 exomes
AF:
0.0185
AC:
4537
AN:
245098
AF XY:
0.0190
show subpopulations
Gnomad AFR exome
AF:
0.00766
Gnomad AMR exome
AF:
0.0171
Gnomad ASJ exome
AF:
0.0800
Gnomad EAS exome
AF:
0.000659
Gnomad FIN exome
AF:
0.00302
Gnomad NFE exome
AF:
0.0228
Gnomad OTH exome
AF:
0.0285
GnomAD4 exome
AF:
0.0213
AC:
31058
AN:
1457958
Hom.:
461
Cov.:
54
AF XY:
0.0213
AC XY:
15474
AN XY:
725400
show subpopulations
African (AFR)
AF:
0.00743
AC:
248
AN:
33378
American (AMR)
AF:
0.0178
AC:
797
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.0801
AC:
2091
AN:
26114
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39662
South Asian (SAS)
AF:
0.00822
AC:
709
AN:
86250
European-Finnish (FIN)
AF:
0.00377
AC:
189
AN:
50128
Middle Eastern (MID)
AF:
0.0609
AC:
351
AN:
5768
European-Non Finnish (NFE)
AF:
0.0226
AC:
25173
AN:
1111664
Other (OTH)
AF:
0.0247
AC:
1491
AN:
60302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
1613
3226
4839
6452
8065
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
968
1936
2904
3872
4840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0169
AC:
2567
AN:
151682
Hom.:
40
Cov.:
34
AF XY:
0.0167
AC XY:
1237
AN XY:
74166
show subpopulations
African (AFR)
AF:
0.00712
AC:
293
AN:
41150
American (AMR)
AF:
0.0245
AC:
373
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.0810
AC:
281
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00685
AC:
33
AN:
4820
European-Finnish (FIN)
AF:
0.00292
AC:
31
AN:
10610
Middle Eastern (MID)
AF:
0.0445
AC:
13
AN:
292
European-Non Finnish (NFE)
AF:
0.0215
AC:
1459
AN:
67924
Other (OTH)
AF:
0.0276
AC:
58
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
122
243
365
486
608
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0297
Hom.:
14
Bravo
AF:
0.0218

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jul 05, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.95
DANN
Benign
0.38
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144347039; hg19: chr9-139327577; API